Sigma Planning Corp - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 327 filers reported holding GW PHARMACEUTICALS PLC in Q2 2019. The put-call ratio across all filers is 1.37 and the average weighting 0.2%.

Quarter-by-quarter ownership
Sigma Planning Corp ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q2 2019$247,000
+2.9%
1,432
+0.6%
0.01%
-7.1%
Q1 2019$240,000
-36.0%
1,424
-34.3%
0.01%
-36.4%
Q3 2018$375,000
+55.0%
2,169
+25.2%
0.02%
+37.5%
Q2 2018$242,000
-2.8%
1,733
-8.1%
0.02%
-15.8%
Q4 2017$249,000
-70.4%
1,886
-84.4%
0.02%
-83.9%
Q4 2015$842,000
-26.3%
12,122
-3.1%
0.12%
-34.8%
Q3 2015$1,143,000
-28.4%
12,514
-3.8%
0.18%
-17.7%
Q2 2015$1,597,000
+33.5%
13,002
-1.0%
0.22%
+39.2%
Q1 2015$1,196,000
+1.3%
13,127
-24.8%
0.16%
+1.3%
Q4 2014$1,181,00017,4450.16%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q2 2019
NameSharesValueWeighting ↓
Lamond Capital Partners LLC 134,230$9,085,0005.95%
VHCP Management, LLC 311,853$21,106,0005.81%
Iguana Healthcare Management, LLC 60,000$4,061,0001.96%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 366,187$24,784,0000.95%
ACUTA CAPITAL PARTNERS, LLC 20,000$1,354,0000.92%
United Asset Strategies, Inc. 14,278$966,0000.41%
PRUDENTIAL PLC 823,408$55,728,0000.24%
Rock Springs Capital Management LP 28,000$1,895,0000.22%
CLOUGH CAPITAL PARTNERS L P 84,600$5,726,0000.20%
Eventide Asset Management 25,000$1,692,0000.18%
View complete list of GW PHARMACEUTICALS PLC shareholders